These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Heat-shock protein 70 acts as an effective adjuvant in neonatal mice and confers protection against challenge with herpes simplex virus. Pack CD; Kumaraguru U; Suvas S; Rouse BT Vaccine; 2005 May; 23(27):3526-34. PubMed ID: 15855011 [TBL] [Abstract][Full Text] [Related]
4. An appraisal of screening for maternal type-specific herpes simplex virus antibodies to prevent neonatal herpes. Rouse DJ; Stringer JS Am J Obstet Gynecol; 2000 Aug; 183(2):400-6. PubMed ID: 10942477 [TBL] [Abstract][Full Text] [Related]
5. [Herpes simplex virus vaccine studies: from past to present]. Us D Mikrobiyol Bul; 2006 Oct; 40(4):413-33. PubMed ID: 17205702 [TBL] [Abstract][Full Text] [Related]
6. Effect of immunization with herpes simplex virus type-1 (HSV-1) glycoprotein D (gD) plus the immune enhancer GPI-0100 on infection with HSV-1 or HSV-2. Quenelle DC; Collins DJ; Marciani DJ; Kern ER Vaccine; 2006 Mar; 24(10):1515-22. PubMed ID: 16288820 [TBL] [Abstract][Full Text] [Related]
7. [Status quo of the researches on HSV vaccines]. Gao J; Lu JC; Huang YF Zhonghua Nan Ke Xue; 2009 Jan; 15(1):60-4. PubMed ID: 19288753 [TBL] [Abstract][Full Text] [Related]
8. Immunotherapeutic activity of a recombinant combined gB-gD-gE vaccine against recurrent HSV-2 infections in a guinea pig model. Manservigi R; Boero A; Argnani R; Caselli E; Zucchini S; Miriagou V; Mavromara P; Cilli M; Grossi MP; Balboni PG; Cassai E Vaccine; 2005 Jan; 23(7):865-72. PubMed ID: 15603886 [TBL] [Abstract][Full Text] [Related]
12. Neonatal herpes simplex virus infections in Canada: results of a 3-year national prospective study. Kropp RY; Wong T; Cormier L; Ringrose A; Burton S; Embree JE; Steben M Pediatrics; 2006 Jun; 117(6):1955-62. PubMed ID: 16740836 [TBL] [Abstract][Full Text] [Related]
13. Clinical trials of prophylactic and therapeutic herpes simplex virus vaccines. Stanberry LR Herpes; 2004 Aug; 11 Suppl 3():161A-169A. PubMed ID: 15319086 [TBL] [Abstract][Full Text] [Related]
14. Keratin, a dual role in herpes simplex virus pathogenesis. Friedman HM J Clin Virol; 2006 Jan; 35(1):103-5. PubMed ID: 15916917 [TBL] [Abstract][Full Text] [Related]
15. The public health imperative for a neonatal herpes simplex virus infection surveillance system. Donoval BA; Passaro DJ; Klausner JD Sex Transm Dis; 2006 Mar; 33(3):170-4. PubMed ID: 16505733 [TBL] [Abstract][Full Text] [Related]
16. The cycle of human herpes simplex virus infection: virus transport and immune control. Cunningham AL; Diefenbach RJ; Miranda-Saksena M; Bosnjak L; Kim M; Jones C; Douglas MW J Infect Dis; 2006 Sep; 194 Suppl 1():S11-8. PubMed ID: 16921466 [TBL] [Abstract][Full Text] [Related]
18. Coexpression of interleukin-2 enhances the immunization effect of a DNA vaccine expressing herpes simplex 1 glycoprotein D. Li WR; Niu B; Wang JW; Feng ZJ; Wang DX Acta Virol; 2006; 50(4):251-6. PubMed ID: 17177610 [TBL] [Abstract][Full Text] [Related]
19. Induction of humoral and cellular immunity against latent HSV-1 infections by DNA immunization in BALB/c mice. Ghaemi A; Soleimanjahi H; Bamdad T; Soudi S; Arefeian E; Hashemi SM; Ebtekar M Comp Immunol Microbiol Infect Dis; 2007 Jul; 30(4):197-210. PubMed ID: 17335902 [TBL] [Abstract][Full Text] [Related]